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Abstract
Background:  Shigellosis remains considerable public health problem in some developing
countries. The nature of Shigellae suggests that they are highly adaptable when placed under
selective pressure in a human population. This is demonstrated by variation and fluctuations in
serotypes and antimicrobial resistance profile of organisms circulating in differing setting in endemic
locations. Antimicrobial resistance in the genus Shigella  is a constant threat, with reports of
organisms in Asia being resistant to multiple antimicrobials and new generation therapies.
Methods: Here we compare microbiological, clinical and epidemiological data from patients with
shigellosis over three different periods in southern Vietnam spanning14 years.
Results: Our data demonstrates a shift in dominant infecting species (S. flexneri to S. sonnei) and
resistance profile of the organisms circulating in southern Vietnam. We find that there was no
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significant variation in the syndromes associated with either S. sonnei or S. flexneri, yet the clinical
features of the disease are more severe in later observations.
Conclusions: Our findings show a change in clinical presentation of shigellosis in this setting, as
the disease may be now more pronounced, this is concurrent with a change in antimicrobial
resistance profile. These data highlight the socio-economic development of southern Vietnam and
should guide future vaccine development and deployment strategies.
Trial Registration: Current Controlled Trials ISRCTN55945881
Background
Shigellosis is an ongoing global public health problem.
Due to the fecal-oral transmission route of the organisms,
the overwhelming burden of shigellosis is found in
resource-poor settings with inadequate sanitation [1,2].
With an estimated number of episodes exceeding 90 mil-
lion per annum in Asia alone, shigellosis represents a sig-
nificant proportion of the total number of bacterial
gastrointestinal infections worldwide [3]. Unlike other
related bacteria which can cause a particular disease syn-
drome in specific locations (e.g. Salmonella Typhi) [4] it is
a disease which "bridges the gap" between industrialized
and developing countries. A report from the National
Center for Infectious Diseases in the United States of
America found the incidence of shigellosis to be 7.6 cases
per 100,000 persons in 1993 [5].
The Shigellae are gram negative, non-motile bacilli of the
larger bacterial family Enterobacteriaceae. S. flexneri are
regarded to be the most abundant globally and are known
to predominate in developing countries [3]. S. sonnei is
the most commonly isolated species in developed coun-
tries, representing over 70% of the total isolates in the
United States of America and Israel [5,6]. The disease syn-
drome associated with these organisms includes fever,
headache, malaise, anorexia and occasionally vomiting,
followed by excretion of profuse watery diarrhea proceed-
ing bloody and/or mucoid diarrhea [7]. All the members
of the genus Shigella are pathogens restricted to infecting
humans and exert their effects on the gastrointestinal
mucosa via the production of a multitude of virulence fac-
tors, including enterotoxins and effector proteins [8,9].
In a recent publication by von Seidlein et al. the authors
found a change in dominant Shigella species related to the
location in Asia (S. sonnei predominated in Thailand, S.
flexneri was dominant in other Asian countries) and fluc-
tuations in S. flexneri serotypes in the same location over
the duration of the study [10]. The authors concluded that
"Shigella appears to be more ubiquitous in Asian impov-
erished populations than previously thought and antibi-
otic-resistant strains of different species and serotypes
have emerged" [10]. Such findings have important impli-
cations for treatment and prevention strategies of shigel-
losis.
On a larger scale, the Shigellae are a group of dynamic
organisms, in which the overall bacterial population
appears to be adaptable with a high recombination rate
and a large amount of imported genetic material in the
genome architecture [11]. These organisms are highly pro-
miscuous regarding their ability to accept horizontally
transferred genetic material. Like E. coli the Shigellae are
successful recipients of numerous plasmids, which may be
transferred from other enteric organisms in the gastroin-
testinal tract [12]. This is supported by evolutionary evi-
dence that the Shigellae are a branch of the E. coli family,
having developed a pathogenic phenotype by the acquisi-
tion of a virulence plasmid and other gene loci and
genomic compensatory mechanisms [13,14].
It is known that the circulating species and serotypes may
be considered a marker of the socio-economic climate in
an individual setting [15]. It is clear that Vietnam has
undergone rapid economic development since the early
1990's. To understand the nature of bacterial and clinical
nature of shigellosis in southern Vietnam we have
amassed and compared microbiological and epidemio-
logical data on childhood shigellosis over three periods
spanning 14 years, from 1995 to 2008.
Methods
Study sites and settings
The primary location was the pediatric gastrointestinal
infections ward at the hospital for tropical diseases (HTD)
in Ho Chi Minh City in southern Vietnam. The HTD is a
500 bed tertiary referral hospital treating patients from the
surrounding provinces and from the districts within Ho
Chi Minh City. The secondary location was Dong Thap
provincial (DTP) hospital in Dong Thap province,
approximately 120 km from the HTD in Ho Chi Minh
City.
Studies contributing data for analysis
Data from three independent studies were combined and
compared. All patients enrolled in the three studies were
treated as inpatients and there were no fatalities. The ini-
tial period (referred to as period A from here onwards)
was a study performed at the pediatric ward at HTD from
January 1995 to August 1996. The enrollment and clinical
observations for this randomized controlled trial are asBMC Infectious Diseases 2009, 9:204 http://www.biomedcentral.com/1471-2334/9/204
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described previously [16]. Briefly, children that were aged
>3 months and < l4 years, admitted to HTD with fever and
bloody diarrhea (bloody diarrhea defined >3 loose stools
with obvious blood) for <5 days were entered into the
study provided that their parents or guardian gave fully
informed consent. Additional strains for microbiological
assessment only (nine in total) were collected for compar-
ison within the same period of the study duration from
DTP. Overall 80 strains were isolated from enrolled chil-
dren over this period; clinical data was available for anal-
ysis on 63 patients with culture confirmed shigellosis.
The secondary period (referred to as period B from here
onwards) was conducted only at the HTD, between March
2000 and December 2002. This period was a clinical and
microbiological investigation of the etiology of diarrhea
in the pediatric population admitted to the HTD in Ho
Chi Minh City. Whilst the treatment criteria for this
descriptive study were not controlled (> 90% of patients
received treatment with fluroquinolones (norfloxacin or
ofloxacin)), the remainder of the criteria for admission to
the study were comparable, children were eligible for
enrollment to the study if consent was given and they
were aged less than 14 years. The obvious variation in the
enrollment for this study was that children were enrolled
on the basis of having any diarrheal syndrome, rather
than specifically targeting those with dysentery and sus-
pected shigellosis. One hundred and fourteen Shigella iso-
lates were recovered during this period; clinical data was
available for analysis on 113 patients.
The final period (referred to as period C from here
onwards) in which data was combined was a trial con-
ducted at the HTD and at DTP between June 2006 and
December 2008. This was a randomized controlled trial
for comparing the treatment of dysentery with cipro-
floxacin and gatifloxacin in Vietnamese children (control-
led trials number ISRCTN55945881) (HV and SB,
unpublished data). The inclusion criteria were as period A.
One hundred and three isolates were collected during this
period and clinical data on all admitted children was
available for analysis.
All three studies were approved ethical assessment by the
Scientific and Ethical Committee of the hospital for trop-
ical diseases and Oxford University tropical ethics com-
mittee (OXTREC) number 010-06 (2006).
Microbiological methods
From all studies, stool samples were collected from
patients and cultured directly on the day of sampling. Ini-
tial isolation was as below, however, all bacterial isolates
were stored in glycerol at -80°C and re-serotyped and
checked for consistency with the original antimicrobial
susceptibility profile for the purposes of this work. All
specimens were processed and checked in the microbiol-
ogy laboratory of the HTD.
Samples were cultured overnight in selenite F broth
(Oxoid, Basingstoke, UK) and onto MacConkey and XLD
agar (Oxoid) at 37°C. Colonies suggestive of Salmonella or
Shigella (non-lactose fermenting) were sub-cultured on to
nutrient agar and were identified using a 'short set' of
sugar fermentation reactions (Kliger iron agar, urea agar,
citrate agar, SIM motility-indole media (Oxoid)). After
incubation for 18 - 24 h at 37°C, the test media were read
for characteristic Shigella reactions and API 20E test strips
of biochemical reactions (Biomerieux, Paris, France) were
used to confirm the identity of Shigella spp. Serologic iden-
tification was performed by slide agglutination with poly-
valent somatic (O) antigen grouping sera, followed by
testing with available monovalent antisera for specific
serotype identification as per the manufacturers recom-
mendations (Denka Seiken, Japan).
Antimicrobial susceptibility testing of all Shigella isolates
against ampicillin (AMP), chloramphenicol (CHL), tri-
methoprim- sulfamethoxazole (SXT), tetracycline (TET),
nalidixic acid (NAL), ofloxacin (OFX) and ceftriaxone
(CRO) was performed by disk diffusion following stand-
ardized Clinical and Laboratory Standards Institute meth-
ods [17]. The minimum inhibitory concentrations (MICs)
were additionally calculated for all isolates by E-test,
according to manufacturer's recommendations (AB Bio-
disk, Solna, Sweden) and were compared to control strain
E. coli ATCC 25922 and an in house fully sensitive E. coli
control.
Clinical observations and statistical analysis
Clinical data was recorded on specialized clinical report
forms for all three studies by clinical staff involved in the
studies. The data collected was related to basic details of
the patient, age (months), sex, location of residence and
weight (kg). A history from all patients was also recorded,
including; duration of illness prior to admission to hospi-
tal (days), fever (defined as a prolonged temperature >
37.5°C), abdominal discomfort, vomiting, watery
diarrhea (defined as three or more loose bowel move-
ments during a 24-h period), bloody or mucoid diarrhea
(defined as >3 loose stools with obvious blood or mucus),
estimated number of episodes of diarrhea before attend-
ing hospital, convulsions believed to be related to fever
and/or infection and if there was any known pretreatment
with antimicrobials. A white blood cell count was per-
formed on all patients and stools were examined by
microscopy (HPF (× 400)) to identify white and red blood
cells, these observations were scored on scale from zero to
three, scale 0 = 0 cells/HPF, scale 1 = 1 to 10 cells/HPF,
scale 2 = 11 to 20 cells/HPF and scale 3 = >20 cells/HPF.
Time in hours (from initial investigation in hospital) toBMC Infectious Diseases 2009, 9:204 http://www.biomedcentral.com/1471-2334/9/204
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the ceasing of bloody/mucoid and watery diarrhea was
recorded. Duration of hospital stay was recorded in days
post admission; patients were only discharged when all
clinical symptoms had resolved completely.
Data were double entered into Microsoft Excel for storage
and manipulation. Mapping data was entered, analyzed
and draw in MapInfo software (Pitney Bowes MapInfo
Corporation, USA). For intergroup comparisons, Chi-
square tests were used for comparison of categorical vari-
ables. For the analysis of continuous variables, Wilcoxon
rank sum, and Kruskal-Wallis test were used for non-nor-
mally distributed data. A p-value of less than 0.05 (two-
tailed) was considered significant. Statistical analysis was
performed in R http://www.r-project.org/.
Results
Epidemiological findings
Over the duration of the three periods spanning 14 years,
228 Shigellae were isolated from children living within 13
districts that constitute Ho Chi Minh City (Figure 1).
Whilst the distribution of the location of the residences of
these patients is biased by referral patterns and people
attending the local hospital (HTD is one of several hospi-
The distribution of the residences of cases of childhood shigellosis admitted to the hospital for tropical diseases in Ho Chi Minh  City Figure 1
The distribution of the residences of cases of childhood shigellosis admitted to the hospital for tropical dis-
eases in Ho Chi Minh City. Over the three periods we were able to positively identify infecting Shigella serotypes in the 
stools of 297 children with symptoms consistent with shigellosis. Of these patients, 228 (76.8%) children lived in the 23 dis-
tricts that constitute Ho Chi Minh City. This figure represents the distribution of the homes of patients reporting to the hospi-
tal for tropical diseases with Shigella isolated from stool, by district. The percentage of cases reporting from each ward is 
distinguished by gradual shading. The location of the hospital for tropical diseases is shown by a yellow star. Large waterways 
(rivers and canals) are shown in dark grey shading.
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tals in the City where children may be treated for gastroin-
testinal infections), the majority of children attending
HTD with culture confirmed shigellosis came from the
three districts within the locality of the hospital (districts
5, 6 and 8), which constitutes a total population of over
800,000 people. In total, the majority of the patients
resided in district eight (n = 88) within approximately 6
km of the hospital. There was no significant change in the
locality of patients over the three periods, or any relation-
ship between serotype and location of the residence of the
patients.
The median age of children with culture confirmed shigel-
losis from all the combined data was 24 months; the age
range was from 3 to 154 months (Figure 2). The number
of children requiring hospital treatment as inpatients for
shigellosis declined significantly after 36 months of age.
The combined data from periods A, B and C demonstrated
some seasonality related to the times of peak infection,
with the majority of cases (> 60%) occurring in the wet
season (between May and September) (Figure 3).
Microbiology and antimicrobial susceptibilities
In total, 297 Shigella strains were isolated from periods A,
B and C. Three were S. boydii, 136 were S. flexneri, 149
were S. sonnei and nine were untypeable. There was a sig-
nificant species shift from S. flexneri to S. sonnei between
period A (29% S. sonnei) and period C (78% S. sonnei)
with an approximate 1:1 ratio of S. flexneri to S. sonnei in
the intermediate period (Figure 4). Apart from S. flexneri
serotype one only being found in period A, there was no
evident fluctuations in S. flexneri populations between the
three periods. The most commonly isolated S. flexneri
serotype was serotype 2a; representing 43% of all the S.
flexneri strains (Table 1).
We identified a significant change in the profile of the pro-
portions of organisms demonstrating resistance to seven
antimicrobials (Figure 5). There was a sequential increase
in the number of Shigellae isolated that were resistant to
nalidixic acid, ofloxacin and ceftriaxone. In period C, 23%
of strains were resistant to ceftriaxone and 68% were
resistant to nalidixic acid (Figure 5). There was an addi-
tional overall increase in the number of antimicrobials to
which the organisms were resistant. During period A, 62%
of all Shigellae were resistant to three or more of the seven
antimicrobials tested, this increased to 87% in period B
and decreased to 83% in period C (Figure 5). The propor-
tion of organisms that were resistant to trimethoprim- sul-
famethoxazole and tetracycline was unchanged between
The combined sex and age distribution of childhood shigellosis patients in southern Vietnam Figure 2
The combined sex and age distribution of childhood shigellosis patients in southern Vietnam. Graph depicts the 
combined age and sex distribution (female - red, male - grey) of 297 children with shigellosis. The black line with boxes repre-
sents the total number of cases per age group specified. The overall age range was from 3 months to 154 months, with a 
median of 24 months. There was no significant relationship of shigellosis with gender; in total, 152 patients were male (51.2%) 
and 145 were female (48.8%).
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the three periods (Figure 5). Between period A and C,
there were significant decreases in the proportions of
organisms resistant to ampicillin, decreasing from 75% to
48%, and chloramphenicol, decreasing from 66% to
30%.
There was a discernible change in sensitivity patterns over
time, which was also related to Shigella species (Table 2).
S. flexneri was significantly more likely to be resistant to
ampicillin in periods A and C and when combined over
all three studies. S. flexneri was also significantly more
likely to be resistant to chloramphenicol in periods B, C
and overall (Table 2). The combined data demonstrated
that S. sonnei was significantly more likely to be resistant
to trimethoprim- sulfamethoxazole and ceftriaxone,
despite ceftriaxone resistance not becoming evident till
period C. The overall pattern of reversion of sensitivity to
ampicillin and chloramphenicol was mainly observed
with respect to S. sonnei isolates. An increase in the
number of organisms resistant to multiple antimicrobials
over time was seen in both Shigella  species. However,
between period A and period C, S. flexneri was more likely
to be resistant to more antimicrobials than S. sonnei (Fig-
ure 6). Resistance to multiple antimicrobials increased
from two to three out of the seven tested from periods A
to C for S. sonnei and from four to five from the seven anti-
microbials tested from periods A to C for S. flexneri (Figure
6).
Clinical features associated with shigellosis
Clinical data was combined and analyzed from all three
studies; this permitted a comparison of some of the fea-
tures of the patients with confirmed shigellosis over the
three studies. Data were available for analysis from 279
patients; 63 patients from period A, 113 patients from
Table 1: Shigella flexneri serotypes isolated in southern Vietnam 
between 1995 and 2008.
S. flexneri serotype Number Percentage (%)
1a 0 0
1b 0 0
1c 4 2.9
2a 59 43.4
2b 8 5.9
3a 13 9.6
3b 2 1.5
3c 16 11.8
47 5 . 1
4a 5 3.7
4b 1 0.7
4x 0 0
5a 0 0
61 3 9 . 6
x0 0
y0 0
Not typed 8 5.9
Total 136 100
The seasonal distribution of shigellosis in southern Vietnam Figure 3
The seasonal distribution of shigellosis in southern Vietnam. southern Vietnam has two distinct seasons, wet and dry. 
The combined data were averaged by calculating the number of months represented to get an overall number of cases per 
month. Red bars; total number of cases, grey bars; average monthly temperature and black line with boxes; average monthly 
rainfall. The seasonal data represents the average rainfall and temperature per month for Ho Chi Minh City.
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period B and 103 patients from period C (Table 3). These
data demonstrated several changes in disease profile over
the three periods. There was a statistically significant
increase in age, which corresponded with an increase in
weight of the children from period A to period C (Table
3). There was decrease in the number of days of history of
the disease symptoms prior to admission to hospital.
There was a statistically significant increase in the number
of children with watery diarrhea, abdominal pain and
febrile convulsions. These clinical features combined sug-
gested a progressively more severe infection syndrome
between 1995 and 2008. Additionally, patients in period
C, had higher white blood cell counts. Over the 14 year
period, patients had a higher density of white cells in their
stool and had longer stays in hospital.
The increase in the severity of the disease was concurrent
with a change in antimicrobial resistance profiles of the
organisms and a change in the dominant Shigella species
isolated. Therefore, these data suggested a more severe dis-
ease pattern may be related to infection with S. sonnei. To
account for any variation in disease syndrome that may be
species specific, the data were analyzed to compare the
clinical syndromes related to species. The data presented
in Table 4 demonstrates only subtle differences between
the syndromes synonymous with the two differing spe-
cies. S. flexneri shows an increase in the number of days of
illness prior to admission in hospital, the number of epi-
sodes of diarrhea, an increase in the duration of mucoid/
bloody diarrhea and the duration of stay in hospital.
Discussion
Our findings demonstrate that the epidemiology of shig-
ellosis infection is similar in southern Vietnam to other
locations in Asia. The main burden of infection in chil-
dren is in those under three years of age [10,15,18,19].
The median age of patients in this investigation was 24
months, this is slightly less than a previous study in Nha
Trang, Central Vietnam [10]. A discrepancy in age in the
two settings may be related to the epidemiological study
being performed with ongoing community surveillance,
rather than those admitted to hospital for treatment. We
also found a pattern of infection which correlated with the
rainy season. The observation that Shigella infections gen-
erally coincide with the wet season in a tropical setting has
been noted before in an urban setting in Jakarta, Indone-
sia [18]. Transmission of Shigella has been associated with
wastewater and river water in Vietnam in two independ-
ent locations in Vietnam [20,21]. An increase in fecal con-
tamination of the water supply due to increased ground
water may account for this pattern as distance to a water
source was found to be associated with higher risk of shig-
ellosis in Nha Trang. The majority of patients enrolled in
the studies combined here resided in District 8 of Ho Chi
Minh City. Although we are unable to draw meaningful
conclusions from the residences of these patients owning
to referral and catchment areas of the HTD, district 8 rep-
resents the area of the city with the greatest density of
canal networks and waterways.
In addition to a species shift over time, there was com-
bined effect on antimicrobial resistance; there was a
marked increase in resistance to ceftriaxone and nalidixic
acid. We have previously reported an alarming increase in
ceftriaxone resistant Shigellae in southern Vietnam [22].
Whilst nalidixic acid is no longer used therapeutically,
resistance increases the MIC to fluoroquinolones, which
are recommended for the treatment of Shigella infections
[23]. Our theory that antimicrobial resistant organisms
are under selective pressure in this population is sup-
The distribution of Shigella species from three childhood  shigellosis studies in southern Vietnam over fourteen years Figure 4
The distribution of Shigella species from three child-
hood shigellosis studies in southern Vietnam over 
fourteen years. The distribution of Shigella species from 
period A (n = 80), period B (n = 114) and period C (n = 103). 
The percentage of S. sonnei and S. flexneri are colored red and 
grey respectively, other Shigella species are colored black. 
The p value was calculated using the chi - squared test.
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Changing antimicrobial resistance patterns of Shigella spp Figure 5
Changing antimicrobial resistance patterns of Shigella spp. All organisms were tested for susceptibility to seven antimi-
crobial agents by the disc diffusion and E-test methods. The antimicrobials tested were as follows, AMP; Ampicillin, CHL; Chlo-
ramphenicol, SXT; Trimethoprim- Sulfamethoxazole, TET; Tetracycline, NAL; Nalidixic Acid, OFX; Ofloxacin and CRO; 
Ceftriaxone. Graph shows the percentage of resistant (red) and sensitive (grey) organisms isolated from periods A, B and C. 
Statistical significance was calculated using a chi squared test.
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Table 2: Comparison of resistance patterns between Shigella flexneri and Shigella sonnei isolated in southern Vietnam between 1995 
and 2008.
Collection Serotype (n) Phenotypeb AMP CHL SXT TET NAL OFX CRO
A (1995 - 1996) sonnei (24) R 11 8 23 23 0 0 0
S1 3 1 6 1 1 2 4 2 4 2 4
flexneri (56) R 54 10 53 53 9 0 0
S 2 46 3 3 47 56 56
p Valuea < 0.0001 0.1287 0.8102 0.8102 0.0371 - -
B (2000 - 2002) sonnei (54) R 50 10 53 52 9 0 1
S 4 44 1 2 45 54 53
flexneri (50) R 46 38 44 49 21 0 0
S 4 12 6 1 29 50 50
p Valuea 0.9316 < 0.0001 0.0415 0.5577 0.0052 - 0.329
C (2007 - 2008) sonnei (71) R 17 5 71 69 51 0 12
S5 4 6 6 0 2 2 0 7 1 5 9
flexneri (30) R 25 28 28 30 19 1 1
S 522 0 1 1 2 9 2 9
p Valuea < 0.0001 < 0.0001 < 0.0001 0.3696 0.4619 0.297 0.076
Combined sonnei (148) R 78 23 147 144 60 0 13
S 70 125 1 4 88 148 135
flexneri (136) R 125 76 125 132 49 1 1
S 11 60 11 4 87 135 135
p Valuea < 0.0001 < 0.0001 0.001 0.613 0.365 0.478 0.002
a p Value calculated using the chi-squared test
b Phenotype with respect to Resistant (R) or Sensitive (S)
AMP; Ampicillin, CHL; Chloramphenicol, SXT; Trimethoprim- Sulfamethoxazole, TET; Tetracycline, NAL; Nalidixic Acid, OFX; Ofloxacin, CRO; Ceftriaxone.
The increasing proportions of antimicrobial resistant S. sonnei and S. flexneri during a fourteen year transition Figure 6
The increasing proportions of antimicrobial resistant S. sonnei and S. flexneri during a fourteen year transition. 
The distribution of the proportion of S. sonnei and S. flexneri isolates that were resistant to one or more of seven antimicrobials 
tested. S flexneri strains (red lines) were significantly more likely to be resistant to more antimicrobials that S. sonnei (black 
lines) over both collections compared. S. sonnei and S. flexneri were significantly more likely to be resistant to more antimicro-
bials when period C (2007 - 2008) (lines with triangles) was compared to period A (1995 - 1996) (lines with squares).
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ported by a sequential decrease in resistance to older anti-
microbial therapies, such as ampicillin and
chloramphenicol which are now rarely used in the com-
munity to treat gastrointestinal infections. The uncon-
trolled use of antimicrobials in this setting may fuel the
spread of multiple drug resistant organisms. However,
due to promiscuous nature of the Shigellae it is likely that
resistance genes are transferred regularly to and from
other enteric bacteria and maintained by selective pres-
sure. The change is species and antimicrobial resistance
pattern reflects a change occurring in the Shigella popula-
tion over time in this setting. Locality and time of isola-
tion data suggest that entrance to all studies was sporadic
and there was no evidence of transient epidemics.
Currently there are several candidate Shigella vaccines in
development, of which some have already been tested in
initial clinical trials [24-27]. The development and
deployment of Shigella vaccines may be hindered by the
number of different species and serotypes circulating in
one setting and in differing locations. For example, S.
flexneri serotypes are known to fluctuate over time, this
has been observed in India, Indonesia, Bangladesh, and
Pakistan, [10,28]. Here, we have demonstrated a signifi-
cant longitudinal transition of species from S. flexneri to S.
sonnei. Vaccine development for shigellosis is challenging
as primary infection offers only serotype specific immu-
nity [29]. A study concerning a cohort of Chilean children
found infection conferred 76% protective efficacy against
re-infection with the same serotype [30]. An option for
controlling shigellosis would be the development of a
series of single serotype vaccines which could be imple-
mented in individual locations with a known serotype
profile. Alternatively, the most cost effective method of
control would be the development of a polyvalent vaccine
offering cross protection to a number of known dominant
Table 3: Clinical results of Shigella infections between 1995 and 2008.
A (1995 - 1996) B (2000 - 2002) C (2007 - 2008) Combined p valuea
Pateints n = 63 n = 113 n = 103 n = 279
Age (months)d 23 (17 - 48) 21 (14 - 29) 30 (19 - 42) 24 (16 - 36) < 0.001
Weight (kg) 10 (9 - 13) 10 (9 - 12) 11.5 (10 - 15) 10.5 (9 - 13) 0.004
Male sex (%) 31 (49) 50 (44) 61 (59) 184 (59%) 0.085
Patient history
Days 2 (1 - 7) 2 (1 - 9) 1 (1 - 4) 2 (1 - 9) < 0.001
Fever (%) 62 (98) 104 (92) 100 (97) 266 (95) 0.09
Abdominal pain (%) 33 (52) 41 (36) 79 (76) 153 (54) < 0.001
Vomitting (%) 24 (38) 64 (56) 51 (49) 139 (50) 0.062
Watery diarrhea (%) 28 (44) 67 (59) 74 (71) 169 (60) 0.002
Bloody/mucoid diarrhea (%) 63 (100) 60 (53) 98 (95) 221 (79) < 0.001
Diahorreal episodes per day NA 8 (5-10) 8 (5-10) 8 (5-10) 0.595
Convulsions (%) 4 (6) 7 (6) 20 (19.4) 31 (11) < 0.001
Known pretreatment (%) 3 (5) 8 (7) 4 (4) 14 (5) 0.543
Clinical details
Serotype sonnei (%) 21/63 (33) 55/113 (49) 71/103 (69) 153/279 (55) < 0.001
White cell count (× 103/mm3) 10 (8.3 - 15) 10.1 (7.7 - 12.8) 13.1 (10.1 - 17.3) 11.3 (8.7 - 15.4) < 0.001
Red cells in stoolb NA 1 1 1 0.715
White cells in stoolb NA 3 3 3 0.02
Mucoid duration (hrs) 31.5 (24 - 53.5) 36 (24 - 54) 28 (18 - 48) 30 (19.5 - 48) 0.113
Diarrhea duration (hrs) 48.5 (29.25 - 87) 48 (24 - 72) 48 (30 - 72) 48 (26.75 - 72) 0.402
Duration of illness
Hospital stay (days) 3 (1 - 12) 4 (1 -15) 5 (2 - 14) 4 (1 -15) < 0.001
Disease duration (days)c 4 (2 - 15) 6 (3 - 18) 6 (3 - 15) 6 (2 - 18) < 0.001
a p Values calculated using either Chi-square test or the Kruskal-Wallis test
b Cells in Stools assessed as described in methods
c Disease duration calculated by addition of history of disease and stay in hospital
d Interquartile range values in brackets unless statedBMC Infectious Diseases 2009, 9:204 http://www.biomedcentral.com/1471-2334/9/204
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serotypes, this approach may aid in tackling the global
burden of shigellosis. The transition of dominant Shigella
species in southern Vietnam has occurred on a back-
ground of economic development and may predict a con-
tinuing cycle in other areas under going similar rapid
economic changes.
Conclusions
What we are unable to specifically ascertain from this
study is the overall incidence and greater epidemiological
picture of shigellosis in this setting. On the basis of these
data a thorough epidemiological assessment of burden is
warranted to calculate the financial and health implica-
tions of any potential future routine vaccination against
shigellosis that may become available. However, here we
have shown a significant transition in Shigella species and
antimicrobial resistance dominance overtime and a con-
current change in the clinical disease presentation.
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Table 4: The clinical presentation of Shigella flexneri and Shigella sonnei infections.
S. flexneri S. sonnei p valuea
Pateints n = 123 n = 147
Age (months)d 25 (12 - 42) 23 (14 - 36) 0.105
Weight (kg) 11 (8.5 - 14) 10 (9.9 -13) 0.558
Male sex (%) 55 (44.7) 83 (56.5) 0.055
Patient history
Days 2 (2 - 3) 1 (1 - 2) < 0.001
Fever (%) 117 (95) 141 (96) 0.761
Abdominal pain (%) 64 (52) 84 (57.1) 0.48
Vomitting (%) 60 (48.8) 74 (50.3) 0.78
Watery diarrhea (%) 78 (63.4) 86 (58.5) 0.41
Bloody/mucoid diarrhea (%) 97 (78.9) 117 (80) 0.88
Diarrhea episodes per day 10 (5 - 10) 8 (5 - 10) 0.051
Convulsions (%) 9 (7.3) 21 (14.3) 0.07
Known pretreatment (%) 7 (5.7) 7 (4.8) 0.585
Clinical details
White cell count (× 103/mm3) 10 (8 - 13.6) 12 (10.5 - 15.5) 0.029
Red cells in stoolb 11 0 . 0 5 6
White cells in stoolb 33 0 . 1 7 3
Mucoid duration (hrs) 36 (24 - 53.5) 25 (18 - 48) 0.054
Diarrhea duration (hrs) 48 (39 - 72) 48 (27 - 72) 0.088
Duration of illness
Hospital stay (days) 5 (4 - 5) 4 (3 - 5) 0.276
Disease duration (days)c 7 (6 - 8) 5 (4 - 7) 0.009
a p Values calculated using either the Chi-square test or the Kruskal-Wallis test
b Cells in Stool assessed as described in methods
c Disease duration calculated by addition of history of disease and stay in hospital
d Interquartile range values in brackets unless statedBMC Infectious Diseases 2009, 9:204 http://www.biomedcentral.com/1471-2334/9/204
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